For long-term investors looking to ride the wave of AI-powered productivity, UiPath might just be one of the more underappreciated names worth watching closely.

Shares of automation software company UiPath (NYSE:PATH) jumped 8.4% in the afternoon session after the stock's positive ...

UiPath 's ( PATH +2.93%) business centers around automating and leveraging artificial intelligence (AI) to save users time.

Most of the residents of Virginia have a computer but not all the computer owners use the internet and those that do use the internet pay an average monthly price of $86.70 which is 12 percent higher ...

Zacks Equity Research shares UiPath PATH as the Bull of the Day and Pilgrim’s Pride PPC as the Bear of the Day. In addition, ...

Cancer, Alzheimer’s, and other diseases follow a pathway in the human body. It starts at the molecular and cellular levels, and through a series of complex interactions can lead to the development and ...

OpenAI recently expanded its CoreWeave agreement, reflecting the burning demand for compute power generated by AI adoption. CoreWeave provides critical cloud infrastructure and GPU computing power. It ...

From the fourth week of October 2025, keychains based on the characters from the upcoming Gnosia anime will appear in Gashapon machines around Japan. It’ll cost 300 JPY ($2.05) per attempt, and there ...

UiPath Chief People Officer Agi Garaba explains why building agent literacy is now as critical as mastering the internet once was - and why the cultural challenge of blending human and digital ...

Continuing its evolution from a robotic process automation provider to an agentic artificial intelligence platform, UiPath Inc. today unveiled a series of new capabilities designed to simplify the ...

U.S. law expiration may reduce private sector's cyber threat info sharing, experts warn Lawmaker says law is vital amid rising cyber threats from foreign adversaries Coalition of 50+ business groups ...

Medical device funding is hitting levels we haven’t seen since 2021, with investors pouring billions into diagnostics and imaging companies. While innovation has raced ahead, a fundamental problem ...